Not exact matches
Through talking to experts in the field over the past year, Gates said he had identified five areas
of need: Understanding better how Alzheimer's unfolds, detecting and diagnosing it earlier, pursuing multiple
approaches to trying to halt the disease, making it easier for people to take part in
clinical trials
of potential new medicines, and
using data better.
To achieve this goal, several
approaches are envisaged: identifying small populations with severe disease where a medicine's benefit - risk balance could be favorable; making more
use of real - world data where appropriate to support
clinical trial data; and involving health technology assessment bodies early in development to increase the chance that medicines will be recommended for payment and ultimately covered by national healthcare systems.
«Through the intense focus our 285,000 colleagues bring to helping people live healthier lives and helping make the health system work better for everyone, we have grown to serve more people in more ways than ever, including through innovative
uses of advanced technologies, data analytics, and modern
clinical approaches that improve quality, lower cost and advance consumer and care provider satisfaction,» David S. Wichmann, CEO
of UnitedHealth Group, said in a conference call.
It does not measure other critical brain functions that can be adversely affected by head trauma, such as balance and vision, which is why expert groups [1] recommend a «multifaceted
approach to concussion management that emphasizes the
use of objective assessment tools aimed at capturing the spectrum
of clinical signs and symptoms, cognitive dysfunction, and physical deficits... that are more sensitive to the injury than
using any one component alone.»
In an effort to find out, Stephen P. Juraschek, M.D., Ph.D., research and
clinical fellow in general internal medicine at the Johns Hopkins University School
of Medicine, and his colleagues
used data from the DASH (Dietary
Approaches to Stop Hypertension)
clinical trial, a widely popular and often - cited study whose results were first published in 1997.
Weiss cautioned that this proof -
of - principle finding is an early step, with many further studies to be done to verify if this
approach will be safe and effective in
clinical use.
In a series
of side - by - side comparisons, Mooney's team demonstrated that APC - mimetic scaffolds performed better than methods involving commercially available expansion beads (Dynabeads), which are currently
used in
clinical adoptive cell transfer
approaches.
Tissue - based planning systems —
using clinical guidelines to determine the optimal breast implant dimensions for individual patients — appear superior to
approaches relying more on the patient's or surgeon's preference, according to the study by Drs. William P. Adams, Jr.,
of University
of Texas Southwestern Medical Center, Dallas, and Daniel McKee
of McMaster University, Hamilton, Ont., Canada.
Instead
of simply tracking what the outlets were publishing and analyzing their impact on public opinion, the researchers took an
approach similar to that
used in
clinical trials to evaluate the effects
of new drugs.
His primary
clinical and research focus is dementia, with specific areas
of interest including biomarkers to assist in the diagnosis and understanding
of disease mechanisms for Alzheimer's and Parkinson's disease, and translational research
using novel therapeutic
approaches.
The MIT researchers have started a company to begin a larger
clinical study for validating this
approach, and they plan to investigate the possibility
of using this technology for other types
of cancer.
This is the first JTFPP guideline that was developed
using a GRADE (Grading
of Recommendations, Assessment, Development and Evaluations) methodology, a very rigorous, systematic, evidence - based
approach to making
clinical recommendations.
«At Exeter we are already developing specific psychological therapies, running
clinical trials
of novel drug
approaches and
using - cutting edge genetic techniques to identify new targets for safe and effective therapies and to allow us to
use current treatments in a more focussed way.»
At today's press conference, both Friedmann and Fischer expressed confidence that their
approach is on the cusp
of mainstream
clinical use.
His laboratory is also keenly interested in utilizing high - throughput proteomic
approaches for the discovery
of biomarkers for diseases such as cancer and exploring the
use of proteomic and metabolomic technology for the routine interrogation
of clinical samples.
«RNAi therapies are a unique
approach to cancer treatment as they have the potential to «turn off» the genes» coding for proteins involved in cancer cell division,» said Ramesh K. Ramanathan, M.D., medical director
of the Virginia G. Piper Cancer Center
Clinical Trials Program at Scottsdale Healthcare and deputy director
of the
Clinical Translational Research Division
of the Translational Genomics Research Institute (TGen) in Phoenix, Ariz. «
Using a lipid nanoparticle, the RNAi drug can be delivered to a cancer cell to block the expression
of specific proteins involved in tumor growth.»
«inStem is
using a large spectrum
of approaches» to both basic research and its
clinical application, he said.
More refinement
of these
approaches are necessary before
clinical use, Â but it illustrates how engineered mixtures
of progenitor cells and supportive materials are becoming increasingly sophisticated and complicated.
According to Dr. Carter, the findings suggest that future
approaches using clinical assessments to identify the specific type
of brain dysfunction contributing to a patient's symptoms may allow a more targeted
approach to treatment.
«Given the broad and growing
use of smartwatches and ready accessibility
of downloadable mobile applications, this
approach may ultimately be applied to efficiently screen for AF,» said senior author Gregory Marcus, MD, MAS, a UCSF Health cardiologist and director
of clinical research in the UCSF Division
of Cardiology.
He noted that while no technique has emerged as a proven
clinical approach, the
use of human rather than rodent cells as demonstrated by Pollok et al. is an important step in advancing the science behind liver cell transplantation.
The
clinical sensitivity in detecting clonality in a majority
of B - cell malignancies can
approach 100 percent when the IGH and IGK assays are
used together.
Our team designed a mixed - methods
approach, utilizing quantitative surveys and qualitative methods, to examine preferences and motivations
of physicians and patients enrolled, evaluate the flow and utilization
of genomic information within the
clinical interactions, and assess understanding, behavior, medical consequences and healthcare costs associated with the
use of WGS in these models
of medical practice.
The Cancer Genome Atlas is
using genomic, transcriptomic, and epigenomic measurements
of cancer cells, coupled with computational
approaches and rich
clinical data, to understand the dysfunctions that underline the onset, progression, and spread
of cancer.
Despite the marginal improvements in survival
of patients suffering from malignant glioma treated with gene therapy vectors, the
clinical trials conducted so far
using viral vectors, in particular adenoviral vectors, have proven that the
use of adenoviral vectors is a safe therapeutic
approach, even in large, multicenter, phase 3
clinical trials.
Lung Cancer is
approached at Penn in a multidisciplinary fashion from both the
clinical and research perspective
using the infrastructure
of the Abramson Cancer Center's interdisciplinary Thoracic Oncology Program (ITOP).
Although
clinical trials have collectively shown a disease control rate
of approximately 45 percent
using this
approach in ovarian cancer, they have yet to establish selective benefit in BRCA1 / 2 - deficient cancers, which should generate stronger anti-tumor immune responses given their higher mutation rate.
One
approach in
clinical trials is to wipe out the patient's immune system
using strong doses
of chemotherapy with antibodies and then
use their own previously banked hematopoietic stem cells (blood forming stem cells) to regenerate the blood system.
While genome editing technology represents a highly promising area to advance the future
of therapy for hematologic disorders, critical questions must be addressed to effectively translate this
approach into
clinical use.
Last month, we published a paper in the BMJ — along with a number
of genetic scientists,
clinical geneticists and other health specialists — advocating an evidence - based
approach that places the emphasis on targeted diagnosis in the short term, and gathering evidence for possible broader
uses in future.
The results here reported are consistent with current knowledge concerning the biological and
clinical effects
of each one
of the elements
used in the
approach described in this study.
The IFN Academy ™
uses a research oriented, evidence - based, systematic yet personalized «case based»
approach in teaching health care practitioners how to
use IFN for the core
clinical imbalances that lie at the root
of most chronic health conditions including:
Functional Medicine is an integrative, science - based healthcare
approach that treats illness and promotes wellness by focusing on the biochemical processes that go on in the body, and the ways that natural substances such as vitamins and herbs can impact those processes — it is a paradigm shift in medicine that
uses recent technological and
clinical advances to treat the underlying causes
of illness.
The Inflammation Research Foundation was founded in 2003 as a non-profit 501c foundation dedicated to providing support for
clinical research projects for the
use of innovative nutritional
approaches to reduce inflammation that is the underlying cause
of many chronic disease conditions.
Research1 shows that there is substantial overlap between
clinical features
of different hereditary cancer syndromes, further supporting the
use of a pan-cancer, multi-gene
approach.
All
of those
approaches are still in
clinical use today.
Breathwork is an increasingly popular experiential
approach to psychotherapy based on the
use of a specific breathing technique, however, claims
of positive mental health outcomes rely on anecdotal
clinical evidence.
«In 2000, backed by over 35 years
of clinical and empirical research, Dr. Neil Clarke Warren transformed the way singles are introduced online when he launched eHarmony - the first relationship service on the Web to
use a scientific
approach to match highly compatible singles.»
As the National Council for Accreditation
of Teacher Education Blue Ribbon Panel noted, «This demanding, clinically based
approach will create varied and extensive opportunities for candidates to connect what they learn with the challenge
of using it, while under the expert tutelage
of skilled
clinical educators.»
However,
clinical research has shown a new
approach to canine and feline periodontal disease prevention that can be
used in conjunction with, or as an alternative to brushing
of the teeth, Oravet.
This article examines these
approaches towards resolving disputes over surplus embryos and considers whether they support the express objectives
of the AHRA and Quebec's Act Respecting
Clinical and Research Activities Relating to Assisted Procreation (Act Respecting Assisted Procreation) to protect the health and well - being
of women, to promote the principle
of free and informed consent and to recognize that women are more directly affected than men by the
use of assisted reproductive technologies (ARTs).
I am inclined toward a Humanistic, Cognitive Behavioral and Family Systems
approach, but am capable
of being effective
using all
clinical frameworks.
New Directions for Youth (North Hollywood, CA) 2009 — 2011 Marriage and Family Therapy Intern • Conducted initial interviews and assessments to develop treatment and recovery plans for program participants as well as involved family members • Obtained family, social, and employment data along with medical and mental health treatment information for
use in process • Served as member
of multi-disciplinary team to review client cases, treatment
approaches,
clinical issues, participant progress and treatment recommendations • Integrate training and various applicable techniques into treatment plans designed to address mental, emotional and family disorders or conditions • Prepared and maintained
clinical case files for
use in diagnostic evaluations and the monitoring
of progress • Coordinated all continuity
of care and other treatment - related services with probation officers, community service professionals and healthcare personnel
I offer individual therapy
using a variety
of clinical approaches.
Blending conventional and alternative
approaches, I
use a variety
of clinical styles which will be most helpful to each client to assist in building the strength to identify and achieve their goals.»
I am a Licensed
Clinical Psychologist who
uses a biopsychosocial
approach to my assessment
of a person's mental health concerns.
«Through the
use of clinical expertise, compassionate communication and discerning intuition, I assist clients utilizing a Solution - Focused and Cognitive Behavioral
approach.
Being skilled at seeing each individual as unique with their own strengths, our staff
uses a wide array
of medical and
clinical experience to offer a proactive
approach to treatment that promotes self - awareness as a vehicle to emotional well - being.
She is interested in
using objective measures
of outcome to demonstrate
clinical changes and in
using these data to guide further development
of the treatment
approach used in this program.
I have extensive experience working with people
of color and LGBTQIA individuals and
use an identity affirming
clinical approach.»